MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$585,835K
Cash and cash
equivalents
$176,346K
Prepaid expenses and
other current assets
$22,563K
Total current assets
$784,744K
Operating lease
right-of-use asset
$2,255K
Property and equipment,
net
$1,130K
Other assets
$888K
Total assets
$789,017K
Total liabilities and
stockholders equity
$789,017K
Total stockholders
equity
$636,008K
Total liabilities
$153,009K
Accumulated deficit
-$1,443,359K
Accumulated other
comprehensive income (loss)
-$558K
Additional paid-in capital
$1,946,844K
Total current
liabilities
$51,805K
Long-term debt, net
$50,436K
Liability related to the
sale of future...
$36,092K
Derivative liability
$12,500K
Other liabilities
$2,176K
Preferred stock-Series
BPreferred Stock
$70,868K
Preferred stock-Series
APreferred Stock
$61,188K
Common stock, 0.01 par
value 200,000,000...
$1,025K
Accrued liabilities
$38,492K
Accounts payable
$13,313K
Back
Back
Balance Sheet
Viridian Therapeutics, Inc. DE (VRDN)
Viridian Therapeutics, Inc. DE (VRDN)
source: myfinsight.com